For weight management (Wegovy / Mounjaro) EMA and Irish prescribing guidance currently restricts weight-loss GLP-1s to adults with (see our full eligibility guide): BMI 30 kg/m (obesity), or BMI 27 kg/m (overweight) plus at least one weight-related condition type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or established cardiovascular disease You should also be willing to engage with lifestyle change (diet and physical activity) these medicines are an addition to, not a replacement for, behaviour change
10.1002/hep.23711 41
Who Should Use This Product: Ideal for individuals looking to support detox pathways, oxidative stress resilience, and healthy energy levelsespecially those exposed to environmental toxins or under high oxidative stress
Rhonda Patrick: I think some of the most well-known mechanisms do have to do with the omega-3 fatty acids being very powerful regulators of the inflammatory process in some way, shape or form
Semaglutide is unchanged: Mira's previous August 2024 review reported $299 per month, and Willow still advertises $299 in July 2026
Regular review of supplement use is advisable, particularly if your health status or medications change
